Moutayakine_2022_Bioorg.Med.Chem_68_116807

Reference

Title : Evaluation of chromane derivatives: Promising privileged scaffolds for lead discovery within Alzheimer's disease - Moutayakine_2022_Bioorg.Med.Chem_68_116807
Author(s) : Moutayakine A , Marques C , Lopez O , Bagetta D , Leitzbach L , Hagenow S , Carreiro EP , Stark H , Alcaro S , Fernandez-Bolanos JG , Burke AJ
Ref : Bioorganic & Medicinal Chemistry , 68 :116807 , 2022
Abstract : Moutayakine_2022_Bioorg.Med.Chem_68_116807
ESTHER : Moutayakine_2022_Bioorg.Med.Chem_68_116807
PubMedSearch : Moutayakine_2022_Bioorg.Med.Chem_68_116807
PubMedID: 35653868

Related information

Citations formats

Moutayakine A, Marques C, Lopez O, Bagetta D, Leitzbach L, Hagenow S, Carreiro EP, Stark H, Alcaro S, Fernandez-Bolanos JG, Burke AJ (2022)
Evaluation of chromane derivatives: Promising privileged scaffolds for lead discovery within Alzheimer's disease
Bioorganic & Medicinal Chemistry 68 :116807

Moutayakine A, Marques C, Lopez O, Bagetta D, Leitzbach L, Hagenow S, Carreiro EP, Stark H, Alcaro S, Fernandez-Bolanos JG, Burke AJ (2022)
Bioorganic & Medicinal Chemistry 68 :116807